Clinical Trial Update: Shield Post-Approval Study Protocol

View source ↗

Summary

This document outlines the SHIELD post-approval study protocol for colorectal cancer and notes that recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Guardant Health, Inc. | Conditions: Colo-rectal Cancer | Status: RECRUITING